> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Pharmacy Compounding Committee to Review 5 Bulk Drugs
- URL: https://www.fdaweb.com/pharmacy-compounding-committee-to-review-5-bulk-drugs/
- Published: 2016-10-05T12:00:00.000Z
- Updated: 2026-09-14T21:37:06.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5137000

*Federal Register* Notice: FDA has announced an 11/3 Pharmacy Compounding Advisory Committee meeting at the agency’s White Oak campus (Silver Spring, MD). The committee intends to discuss five bulk drug substances nominated for inclusion on the agency’s listing of bulk drugs for use in compounding — glycolic acid, trichloroacetic acid, kojic acid, diindolylmethane, and vasoactive intestinal peptincyde. To view this notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2016-10-05/pdf/2016-24085.pdf?ref=fdaweb.com).